Article
The CDC has addressed the effects and the issues of domestic and international travel on its website. Below is a sampling of key advice.
All News
Article
"If you're having trouble paying for your medications, Drug Company X may be able to help."
Article
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more...
Dr. John Cush
Tweet
Travel During COVID-19 Pandemic--The CDC has addressed the effects and the issues of domestic and international travel on its website.
Read the full article for more information.
https://t.co/wtn5dV6swM https://t.co/0HdC5CfUop
Dr. John Cush
Tweet
44 pts of Inclusion body myositis were randomized to either PBO or sirolimus 2 mg/d. At 12 mos there were no signif differences betw groups for motor strength , but sirolimus had more SAEs (45 vs 27%); yet sirolimus had better HAQ, FVC & 6-min walk times. https://t.co/YhnRTnaGFl
Dr. John Cush
Tweet
The NEJM has featured an overview of Osteoarthritis of the Knee. https://t.co/1AaNICygOr
Dr. John Cush
Tweet
Belated congratulations to Dr. David T. Felson, for receiving the Lee C. Howley, Sr. Prize for Arthritis Science from the Arthritis Foundation. He is a professor of medicine and epidemiology at Boston University's Schools of Medicine and Public Health https://t.co/U7yKnWWLxc
Dr. John Cush
Tweet
ACR Convergence 2020 Fireside Chats- top presentations in nr-axSpA, AS, axial PsA and Still’s disease.
Sponsored by Novartis Medical Affairs
Unable to attend the key sessions at #ACR20? Listen to the experts as they weigh in on the top abstracts.
https://t.co/cUj5T3reyG
Dr. John Cush
Tweet
New QD Clinic—This week’s videos: Clinic Emergencies, Stopping Meds, 3 Issues After COVID Vaccination, My New Clinic COVID Routine, Raynaud's or Not
https://t.co/R0zcRq6Sg1
Dr. John Cush
Tweet
Copay Assistance Programs Help Patients but Confuse Them Too
https://t.co/WuPkwrE3ZF
Dr. John Cush
Tweet
Type I interferon (IFN1) produced by plasmacytoid dendritic cells are prime drivers of adaptive immunity. Study of 137 SLE pts shows that baseline IFN1 scores correl w/ Dz activity, # flares, prednisone doses, immunosuppressive use over 5 yrs https://t.co/OGb4NfrcIU
Dr. John Cush
Tweet
RheumNow Podcast Now UP – Steroids, IVIG & the Vaccine.
How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more...
https://t.co/f0wWTm2kV5
Dr. John Cush
Tweet
New Download Available on COVID-19 & mRNA Vaccines
https://t.co/mvmn17Fl3B https://t.co/ceICzbDZi5
Dr. John Cush
Tweet
QD Clinic - What to do After COVID Vaccination
https://t.co/25RcMOdAkK https://t.co/EWnYJGNqvY
Dr. John Cush
Tweet
2020 Rheumatology Year in Review-- Read our top news items that rheumatologists should recollect and integrate into clinical standards for 2021 and beyond.
https://t.co/QisCpdcLEa https://t.co/pZekUvcomE
Dr. John Cush
Tweet
Rheumatologists: Record your question or case for the RheumNow podcast.
https://t.co/wzNmOzH4VE https://t.co/dgTTvRqESI
Dr. John Cush
Tweet
ProDERM Study: IVIG in Dermatomyositis--The ProDERM study show that IVIg is safe, effective and superior to placebo in patients with dermatomyositis (DM).
https://t.co/HOB8CYn9yc https://t.co/AmT3AQdawa
Dr. John Cush
Tweet
Real good historic review of RA drug development wherein Dr Paul Emery interviews Dr. Mike Weinblatt - Good Listen from the Cytokine Signaling Forum podcast https://t.co/R7rg7AwVlG
Dr. John Cush
Tweet
QD Clinic - Stopping Meds
https://t.co/zhtAHLeGqT https://t.co/rFmCch4WJ4
Dr. John Cush
Tweet
ACR Convergence 2020 Fireside Chats – top presentations in Still’s disease
Sponsored by Novartis Medical Affairs
Unable to attend all the key sessions at ACR Convergence 2020? Listen to the experts as they present their views on the top abstracts.
https://t.co/MD6lU5oIvy
